Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Low protein bread
0904010X0AAAAAA
|
Low protein (bread) | Low protein breads | Nutrition and Blood | No data available |
|
Low protein gluten free biscuits
0904010Z0AAAAAA
|
Gluten free /low protein (biscuits) | Gluten free/low protein biscuits | Nutrition and Blood | No data available |
|
Low protein gluten free bread
0904010F0AAAAAA
|
Gluten free /low protein (bread) | Gluten free/low protein bread | Nutrition and Blood | No data available |
|
Low protein gluten free cheese
0904010AFAAAAAA
|
Gluten free /low protein (sweet/savoury) | Gluten free/low protein sweet/savoury | Nutrition and Blood | No data available |
|
Low protein gluten free egg white replacer
090401050AAABAB
|
Gluten free /low protein (cooking aids) | Gluten free/low protein cooking aids | Nutrition and Blood | No data available |
|
Low protein gluten free mix
0904010E0AAAFAF
|
Gluten free /low protein (mix) | Gluten free/low protein mixes | Nutrition and Blood | No data available |
|
Low protein gluten free pasta
0904010T0AAADAD
|
Gluten free /low protein (pasta) | Gluten free/low protein pasta | Nutrition and Blood | No data available |
|
Low protein mix
090401010AAAAAA
|
Low protein (mix) | Low protein mixes | Nutrition and Blood | No data available |
|
Low protein pasta
0904010AQAAAAAA
|
Low protein (pasta) | Low protein pastas | Nutrition and Blood | No data available |
|
Loxapac 10mg capsules
0402010M0BBAAAA
|
Loxapac | Loxapine succinate | Central Nervous System | No data available |
|
Loxapac 25mg capsules
0402010M0BBABAB
|
Loxapac | Loxapine succinate | Central Nervous System | No data available |
|
Loxapac 50mg capsules
0402010M0BBACAC
|
Loxapac | Loxapine succinate | Central Nervous System | No data available |
|
Loxapine 10mg capsules
0402010M0AAAAAA
|
Loxapine succinate | Loxapine succinate | Central Nervous System | No data available |
|
Loxapine 25mg capsules
0402010M0AAABAB
|
Loxapine succinate | Loxapine succinate | Central Nervous System | No data available |
|
Loxapine 50mg capsules
0402010M0AAACAC
|
Loxapine succinate | Loxapine succinate | Central Nervous System | No data available |
|
Lozamine 3mg lozenges
1203030Y0BBAAAA
|
Lozamine | Benzydamine hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Lubion 25mg/1.112ml inj pre-filled syringes
0604012S0BPACCF
|
Lubion | Progesterone | Endocrine System | No data available |
|
Lubion 25mg/1.119ml solution for injection vials
0604012S0BPAACB
|
Lubion | Progesterone | Endocrine System | No data available |
|
Luborant spray
1203050A0BCAAAF
|
Luborant | Artificial saliva products | Ear, Nose and Oropharynx | No data available |
|
Lubri-Tears eye ointment
1108010L0BDAAAD
|
Lubri-Tears | Liquid paraffin | Eye | No data available |
|
Lucentis 1.65mg/0.165ml inj pre-filled syringes
1108020ADBBACAC
|
Lucentis | Ranibizumab | Eye | No data available |
|
Lucentis 2.3mg/0.23ml solution for injection vials
1108020ADBBABAB
|
Lucentis | Ranibizumab | Eye | No data available |
|
Lucentis 3mg/0.3ml solution for injection vials
1108020ADBBAAAA
|
Lucentis | Ranibizumab | Eye | No data available |
|
Lucozade Energy Glucose tablets orange
0913541C0BDAAAA
|
Lucozade tablets OTC glucose for diabetic hypo treatment | Tablets OTC glucose for diabetic hypo treatment (0913541) | Nutrition and Blood | No data available |
|
Lucozade Energy Glucose tablets original
0913541C0BDABAA
|
Lucozade tablets OTC glucose for diabetic hypo treatment | Tablets OTC glucose for diabetic hypo treatment (0913541) | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.